Literature DB >> 11847001

Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors.

Emanuela Moroni1, Patrizia Dell'Era, Marco Rusnati, Marco Presta.   

Abstract

Fibroblast growth factors (FGFs) belong to a family of pleiotropic heparin-binding growth factors. They exert multiple functions on various cell types of mesodermal and neuroectodermal origin, affecting cell proliferation, motility, survival, and differentiation. FGF's exert their activity by interacting with tyrosine kinase receptors (FGFRs) and cell-surface heparan sulfate proteoglycans. This article reviews recent studies on the role of the FGF/FGFR system in embryonic hematopoietic development, hematopoiesis, and hematological tumors. FGFs exert both autocrine and paracrine functions in these biological processes by acting on blood cells and their precursors and accessory cells in the bone marrow, including stromal and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847001     DOI: 10.1089/152581602753448513

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  17 in total

1.  Fgf21 is essential for haematopoiesis in zebrafish.

Authors:  Hajime Yamauchi; Yuhei Hotta; Morichika Konishi; Ayumi Miyake; Atsuo Kawahara; Nobuyuki Itoh
Journal:  EMBO Rep       Date:  2006-04-13       Impact factor: 8.807

Review 2.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 3.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

4.  Extracellular matrix-modulated Heartless signaling in Drosophila blood progenitors regulates their differentiation via a Ras/ETS/FOG pathway and target of rapamycin function.

Authors:  Michelle Dragojlovic-Munther; Julian A Martinez-Agosto
Journal:  Dev Biol       Date:  2013-04-18       Impact factor: 3.582

5.  FGF signaling facilitates postinjury recovery of mouse hematopoietic system.

Authors:  Meng Zhao; Jason T Ross; Tomer Itkin; John M Perry; Aparna Venkatraman; Jeffrey S Haug; Mark J Hembree; Chu-Xia Deng; Tsvee Lapidot; Xi C He; Linheng Li
Journal:  Blood       Date:  2012-07-16       Impact factor: 22.113

Review 6.  The biochemistry of hematopoietic stem cell development.

Authors:  P Kaimakis; M Crisan; E Dzierzak
Journal:  Biochim Biophys Acta       Date:  2012-10-12

7.  Axl activates fibroblast growth factor receptor pathway to potentiate survival signals in B-cell chronic lymphocytic leukemia cells.

Authors:  S Sinha; J Boysen; M Nelson; S L Warner; D Bearss; N E Kay; A K Ghosh
Journal:  Leukemia       Date:  2015-11-24       Impact factor: 11.528

Review 8.  Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Authors:  Ayalew Tefferi; Animesh Pardanani
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

9.  Effects of fibroblast growth factor 9 (FGF9) on steroidogenesis and gene expression and control of FGF9 mRNA in bovine granulosa cells.

Authors:  Nicole B Schreiber; Leon J Spicer
Journal:  Endocrinology       Date:  2012-07-13       Impact factor: 4.736

10.  What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Authors:  P Schneider; I Dubus; F Gouel; E Legrand; J P Vannier; M Vasse
Journal:  Adv Hematol       Date:  2011-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.